Derek Ragusa is a seasoned leader in biotechnology with extensive experience in clinical program management, currently serving as Clinical Program Lead for Felzartamab at Biogen, a position held since 2024. Previously, Derek held the role of Vice President at UNITY Biotechnology from 2017 to 2024, where they directed innovative product strategies and led development programs across various phases. Their career includes significant positions at Gilead Sciences and Amgen, where they advanced projects in oncology and portfolio management. With a strong foundation in technical operations established during their tenure at Celgene, Derek has demonstrated a commitment to operational excellence and collaborative advancement in drug development throughout their career.
This person is not in the org chart
This person is not in any teams
This person is not in any offices